ZNTLZentalis Pharmaceuticals, Inc.
3.825USD-0.39%Mkt Cap: 362.12M $P/E: —3d ago
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenose…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap362.12M $
Enterprise Value138.30M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-137.06M $
Revenue/Share—
Last Price3.825 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees106
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.13
PEG—
EV/EBITDA-0.92
EV/Revenue—
P/S—
P/B1.50
EPS (TTM)-1.96
EPS (Forward)-1.80
52W Range
1.21246% of range6.950
52W High6.950 USD
52W Low1.212 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-63.39%
ROA-47.43%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-125.25M $
CapEx (TTM)—
FCF Margin—
FCF Yield-21.94%
Net Debt-136.92M $
Net Debt/EBITDA0.91
Balance Sheet
Debt/Equity0.17
Current Ratio4.82
Quick Ratio4.64
Book Value/Sh2.567 USD
Cash/Share2.436 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.889 USD
Upside (mean)+80.1%
Target Range4.000 USD – 10.00 USD
$4.000+80.1% to mean$10.00
# Analysts9
Ownership
Shares Out.94.67M
Float48.97M
Insiders17.18%
Institutions50.88%
Short Interest
Short Ratio4.6d
Short % Float9.73%
Short % Out.7.78%
Shares Short5.58M
Short (prev mo.)5.87M
Technical
SMA 504.329 (-11.7%)
SMA 2003.118 (+22.7%)
Beta1.89
S&P 52W Chg18.16%
Avg Vol (30d)1.24M
Avg Vol (10d)1.49M
Technical Indicators
RSI (14)40.3
MACD-0.1938
MACD Signal-0.1000
MACD Hist.-0.0938
BB Upper5.247 USD
BB Middle4.347 USD
BB Lower3.447 USD
BB Width41.40%
ATR (14)0.3446 USD
Vol Ratio (20d)0.64x